Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Oliver A. Sartor
Based on 148 articles published since 2007
||||
Expertise Level
The expertise of Oliver A. Sartor ranks in the
  • Top 0.0085%
  • ... of 129,228 published authors worldwide on Prostatic Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 148 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Sartor, O   ·   Sartor, Oliver   ·   Sartor, Oliver A
Work Locations
Details
Most likely:    Miscellaneous institutions in New Orleans      
2018
  • From Tulane Medical School, New Orleans (O.S.); and the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London (J.S.B.). · Pubmed 29412780
2017
  • Department of Surgery, Section of Urologic Oncology, School of Medicine, University of Colorado Denver, Aurora, CO. · Department of Medicine (Medical Oncology), Yale (Smilow) Cancer Center, New Haven, CT; Department of Urology, Yale (Smilow) Cancer Center, New Haven, CT. · Department of Medicine, Tulane Cancer Center, New Orleans, LA; Department of Urology, Tulane Cancer Center, New Orleans, LA. Electronic address: · Pubmed 28283376
  • Departments of Medicine and Urology, Tulane Cancer Center, New Orleans, USA. · Academic Unit of Clinical Oncology, University of Sheffield, Weston Park Hospital, Sheffield, UK. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway. · Department of Clinical Oncology, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland. · Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, USA. · Department of Medical Oncology and Radiotherapy, University of Oslo, Norwegian Radium Hospital, Oslo, Norway. · Oncology Global Medical Affairs, Bayer HealthCare Pharmaceuticals, Whippany, USA. · Infinity Analytics Group Inc, Madison. · Department of Statistics, Oncology, Bayer HealthCare Pharmaceuticals, Whippany, USA. · Quantitative Health Sciences, Cleveland Clinic, Cleveland, USA. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK. · Pubmed 28453701
  • The Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, UK. Electronic address: · Bayer HealthCare Pharmaceuticals, 100 Bayer Boulevard, Whippany, NJ 07981, USA. · Yale University, New Haven, CT 06520, USA. · Comprehensive Cancer Center of Nevada, 3730 South Eastern Avenue, Las Vegas, NV 89169, USA. · Karolinska University Hospital, SE-171 76, Stockholm, Sweden. · Tulane Cancer Center, 150 South Liberty Street, New Orleans, LA 70112, USA. · Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Weston Park Hospital, Sheffield, UK. · Pubmed 27930924
  • Comprehensive Cancer Centers of Nevada, Department of Medical Oncology, Las Vegas, NV. Electronic address: · Weston Park Hospital, Department of Oncology, Sheffield, UK. · Washington University School of Medicine, Radiation Oncology, St Louis, MO. · Karolinska University Hospital, Department of Oncology, Stockholm, Sweden. · Queen's University, Centre for Cancer Research and Cell Biology, Belfast, UK. · Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Academic Urology Unit, Sutton, UK. · Umeå University, Department of Radiation Sciences, Umeå, Sweden. · Statisticon AB, Biostatistics Department, Uppsala, Sweden. · Bayer HealthCare Pharmaceuticals, Global Medical Affairs Oncology, Whippany, NJ. · Bayer HealthCare Pharmaceuticals, US Medical Affairs Oncology, Whippany, NJ. · Tulane Cancer Center, Departments of Medicine and Urology, New Orleans, LA. · Pubmed 27613490
  • Associate Professor of Radiation Oncology, Department of Radiation Oncology, Stanford University, Stanford, CA. · Director, Molecular Imaging Program, National Cancer Institute, Rockville, MD. · Section Head, Surgical Pathology, Robert J. Tomisch Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH. · Hematology/Oncology Section Chief and Professor of Radiation Oncology, Departments of Medicine and Urology, Tulane Medical School, New Orleans, LA. · Chair, Department of Radiation Oncology, and Professor of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA. · Chair, Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN. · Chair, Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH. · Chief of Urologic Oncology, Department of Urology, University of Washington, and Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 28222223
  • College of Life Sciences, National Engineering Laboratory for AIDS Vaccine, Jilin University, Changchun, China. · Department of Structural and Cellular Biology, Tulane Cancer Center, New Orleans, Louisiana. · Department of Pathology and Laboratory Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Urology, Tulane Cancer Center, New Orleans, Louisiana. · Department of Medicine, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Pathology, New York University School of Medicine, New York, New York. · College of Life Sciences, National Engineering Laboratory for AIDS Vaccine, Jilin University, Changchun, China. · Pubmed 27671337
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address: · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. · Department of Medicine, Tulane Cancer Center, New Orleans, LA. · Pubmed 27651103
2016
  • From the Departments of Medicine & Urology, Tulane Medical School, New Orleans, LA. · Pubmed 27749328
  • Department of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Urology, Tulane Cancer Center, New Orleans, Louisiana. · Marie Curie Research Wing for Oncology, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom. · Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, United Kingdom. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, University of Nevada School of Medicine and Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. · Department of Global Clinical Development, Bayer HealthCare Pharmaceuticals, Whippany, New Jersey. · Department of Study Management Europe, Bayer AS (formerly Algeta ASA), Oslo, Norway. · Department of Biostatistics, Statisticon AB, Uppsala, Sweden. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 27004570
  • Department of Oncology, Karolinska University Hospital, Stockholm, Sweden · Bayer HealthCare, Whippany. · Departments of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, USA. · Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield. · Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK. · Department of Statistics, Yale University, New Haven, USA. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK. · Pubmed 26912557
  • Department of Oncology, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland; Department of Internal Medicine, Stadtspital Waid, Tièchestrasse 99, 8037 Zurich, Switzerland. · Clinical Trial Unit, CTU, University Hospital of Basel, Schanzenstrasse 55, 4031 Basel, Switzerland. · Department of Oncology, University Hospital of Basel, Petersgraben 4, 4031 Basel, Switzerland. · Erasmus MC, and ErasmusMC Cancer Institute, PO Box 5201, 3008 AE Rotterdam, The Netherlands. · Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5, UK. · Department of Medicine & Urology, Tulane Cancer Center, 1430 Tulane Avenue, SL-42, New Orleans, 70112 LA, USA. · Pubmed 26829012
  • Royal Marsden Hospital, Sutton, London, UK. Electronic address: · Cancer Treatment Centers of America, Tulsa, OK, USA. · Washington University School of Medicine, St Louis, MO, USA. · Center for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Norwegian Radium Hospital, Oslo, Norway. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · University of Sheffield, Sheffield, South Yorkshire, UK. · Karolinska University Hospital, Stockholm, Sweden. · Tulane Cancer Center, New Orleans, LA, USA. · Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA. · St. James University Hospital, Leeds, Yorkshire, UK. · Pubmed 27344296
2015
  • Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Department of Medicine: Section of Hematology & Medical Oncology and Department of Urology, Tulane Medical School, New Orleans, LA. · Department of Pathology, University of Arizona College of Medicine, Tucson, AZ. · College of Pharmacy, Medical University of South Carolina Cancer Center, Charleston, SC. · Pubmed 25623704
  • Tulane Medical School, New Orleans, LA, USA. · Pubmed 25510569
  • San Bernardino Urological Associates, 489 E. 21 Street, San Bernardino, CA 92404, USA. Electronic address: · Medicine and Urology Departments, Tulane School of Medicine, Box SL-42 1430 Tulane Ave, New Orleans, USA. · Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, 111 South 11th Street, Philadelphia, PA 19107, USA. · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, USA. · GlaxoSmithKline, 5 Moore Drive, PO Box 13398, Research Triangle Park, North Carolina, NC 27709, USA. · Pubmed 26048455
  • Departments of Medicine and Urology, Tulane Medical School, New Orleans, LA. · Oxford Outcomes Inc, an ICON plc company, Bethesda, MD. Electronic address: · Oxford Outcomes Inc, an ICON plc company, Bethesda, MD. · Millennium Pharmaceuticals Inc, The Takeda Oncology Company, Cambridge, MA. · Bruce Wong & Associates Inc. · Pubmed 25262852
  • Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana. · Pubmed 26452186
2014
  • Princess Margaret Hospital, Toronto, ON, Canada. Electronic address: · Durham VA Medical Center and Duke University Medical Center, Durham, NC, USA. · BC Cancer Agency, Vancouver, BC, Canada. · Seattle Cancer Centre Alliance, Seattle, WA, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Royal Marsden NHS Foundation Trust, Sutton, UK. · Tulane Cancer Center, New Orleans, LA, USA. · University of Montreal Hospital Center, Montreal, PQ, Canada. · Pubmed 23957948
  • Mount Vernon Cancer Centre, Northwood, Middlesex, UK. Electronic address: · Tulane Cancer Center, New Orleans, LA, USA. · Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Ullevål University Hospital, Oslo, Norway. · Haukeland University Hospital, Bergen, Norway. · Christie Hospital, Manchester, UK. · St James's University Hospital, Leeds, UK. · Karolinska University Hospital, Stockholm, Sweden. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA. · Algeta ASA (Bayer), Oslo, Norway. · The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 25439694
  • Tulane Cancer Center, New Orleans, LA, USA. Electronic address: · Weston Park Hospital, Sheffield Cancer Research Centre, Sheffield, UK. · Karolinska University Hospital, Radiumhemmet, Stockholm, Sweden. · Akershus University Hospital, Department of Oncology, Lørenskog, Norway. · Haukeland University Hospital, Bergen, Norway. · Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Oslo University Hospital, Radiumhospital, Oslo, Norway. · Hospital Chomutov, Nuclear Medicine Department, Chomutov, Czech Republic. · Centrum Onkologii-Instytut im Marii Skodowskiej-Curie, Warsaw, Poland. · Christie Hospital, Manchester, UK. · Umeå University, Department of Radiation Sciences, Oncology, Sweden. · Ullevål University Hospital, Oslo, Norway. · Mount Vernon Hospital Cancer Centre, Northwood, Middlesex, UK. · Cancer Research Unit, University of Warwick, Coventry, UK; University Hospital, Birmingham NHS Trust, Birmingham, UK. · St Olavs Hospital, Trondheim, Norway. · Clatterbridge Cancer Centre, Clatterbridge Health Park, Bebington, Wirral, UK. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Algeta ASA, Kjelsaas, Oslo, Norway. · Bayer Healthcare, Whippany, NJ, USA. · Norwegian Radium Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway. · The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 24836273
  • Department of Urology and Medicine, Tulane Medical School, Tulane, New Orleans, Louisiana, USA. · Pubmed 24994787
  • Department of Urology, Medical University of South Carolina, Charleston, SC. · Tulane Cancer Center, New Orleans, LA. · Hollings National Cancer Institute Comprehensive Cancer Center, Charleston, SC; Center for Medication Safety and Efficacy, the Medical University of South Carolina, Charleston, SC; University of South Carolina, Columbia, SC. · Pubmed 24680449
2013
2009
2008
  • Stanley Scott Cancer Center, New Orleans, Louisiana, USA. · Pubmed 18681353
2012
  • Department of Structural & Cellular Biology, School of Medicine, New Orleans, LA, USA. · Pubmed 22461511
  • Division of Hematology/Oncology, Department of Medicine, Tulane Cancer Center, New Orleans, Louisiana, USA. · Pubmed 22453334
2011
  • Tulane Medical School, New Orleans, Los Angeles and USA. · Pubmed 21734581
Probable:    Tulane University   Contact    
2017
  • Sage Bionetworks, Seattle, WA, USA. · Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Department of Mathematics and Statistics, University of Turku, Turku, Finland; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. · Department of Pharmacology and Computational Biosciences Program, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. · Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. · Department of Information Technology, University of Turku, Turku, Finland. · Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland; Department of Pathology (HUSLAB), Helsinki University Hospital, Helsinki, Finland. · Sanofi, Bridgewater, NJ, USA. · AstraZeneca, Gaithersburg, MD, USA. · IBM T J Watson Research Center, IBM, Yorktown Heights, NY, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Genitourinary Medical Oncology Program, Division of Hematology and Oncology, University of California, San Francisco, CA, USA. · Genitourinary Oncology Services, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Tulane Cancer Center, Tulane University, New Orleans, LA, USA. · Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA; The Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Lyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Department of Pharmacology and Computational Biosciences Program, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA; University of Colorado Comprehensive Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. Electronic address: · Pubmed 27864015
  • Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania. · NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania. · Tulane University Cancer Center, New Orleans, Louisiana. · Department of Urology, McMaster University, Hamilton, Ontario, Canada. · Gamma Knife Center, University of Minnesota Medical Center, Minneapolis, Minnesota. · Minneapolis Radiation Oncology, Minneapolis, Minnesota. · Department of Radiation Oncology, Virginia Mason Medical Center, Seattle, Washington. · Department of Radiation Oncology, Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin. · Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri. · Southeast Radiation Oncology, Charlotte, North Carolina. · Arizona Oncology Services, Phoenix, Arizona. · Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California. · Pubmed 28323339
  • College of Life Sciences, National Engineering Laboratory for AIDS Vaccine, Jilin University, Changchun, China. · Department of Structural and Cellular Biology, Tulane Cancer Center, New Orleans, Louisiana. · Department of Pathology and Laboratory Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Urology, Tulane Cancer Center, New Orleans, Louisiana. · Department of Medicine, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Pathology, New York University School of Medicine, New York, New York. · College of Life Sciences, National Engineering Laboratory for AIDS Vaccine, Jilin University, Changchun, China. · Pubmed 27671337
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Urology and Medicine, Tulane University School of Medicine, New Orleans, Los Angeles. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27489290
  • Institute of Cancer Research, London, United Kingdom · Johns Hopkins University, Baltimore, MD · Tulane University School of Medicine, New Orleans, LA · Pubmed 29083122
2016
  • Department of Urology, College of Medicine, Howard University, Washington, DC. Electronic address: · Dendreon Pharmaceuticals Inc, Seattle, WA. · Departments of Urology and Medicine, Tulane University School of Medicine, New Orleans, LA. · Pubmed 26786562
  • Department of Urology, Tulane University School of Medicine, New Orleans, LA; Southeast Louisiana Veterans Health Care Services, New Orleans, LA. · Department of Urology, Tulane University School of Medicine, New Orleans, LA. · Department of Pathology, Tulane University School of Medicine, New Orleans, LA. · Department of Urology, Tulane University School of Medicine, New Orleans, LA; Southeast Louisiana Veterans Health Care Services, New Orleans, LA. Electronic address: · Pubmed 27155916
  • Department of Structural and Cellular Biology, Tulane University, New Orleans, LA 70112, USA. · Department of Dermatology, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524001, China. · Department of Pathology, Ochsner Clinic Foundation, New Orleans, LA 70130, USA. · Department of Computer Science and Biostatistics Facility of RCMI Cancer Research Center, Xavier University of Louisiana, New Orleans, LA 70125, USA. · Department of Pathology and Laboratory Medicine, Tulane University, New Orleans, LA 70112, USA. · Tulane Cancer Center, Louisiana Cancer Research Consortium, Tulane University, New Orleans, LA 70112, USA. · Tulane Center for Stem Cell Research and Regenerative Medicine, Tulane University, New Orleans, LA 70112, USA. · Department of Urology, Tulane University, New Orleans, LA 70112, USA. · Department of Medicine, Tulane University, New Orleans, LA 70112, USA. · Department of Biostatistics and Bioinformatics, Tulane University, New Orleans, LA 70112, USA. · Proteomics/Mass Spectrometry Facility, University at Albany, Rensselaer, NY 12144, USA. · Department of Orthopaedic Surgery and Tulane Center for Aging, Tulane University, New Orleans, LA 70112, USA. · Pubmed 26871944
  • Tulane University School of Medicine, New Orleans, LA. · Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA. · Department of Internal Medicine, University of Massachusetts Medical School, Worcester, MA. · Department of Urology, Tulane University School of Medicine, New Orleans, LA. · Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA; Departments of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA. Electronic address: · Pubmed 26703881
  • Tulane University School of Medicine, New Orleans, LA. · Tulane Cancer Center, New Orleans, LA. · Tulane University School of Medicine, New Orleans, LA; Tulane Cancer Center, New Orleans, LA. Electronic address: · Pubmed 26684813
2015
  • Tulane University School of Medicine, New Orleans, LA. · The Southern Network on Adverse Reaction (SONAR) project, the South Carolina Center of Economic Excellence for Medication Safety, the South Carolina College of Pharmacy, University of South Carolina, Columbia, SC; The Hollings Cancer Center, Medical University of South Carolina, Charleston, SC. · Pubmed 25530377
  • Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Department of Internal Medicine, Section of Medical Oncology, UAB Medical Center, Birmingham, AL, USA. · Department of Medicine and Urology, Tulane University, New Orleans, LA, USA. · Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 26153564
  • Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York. · Departments of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana. · Department of Clinical Oncology, Institute of Cancer Research, Sutton, United Kingdom. · Department of Oncology, Norwegian Radium Hospital and Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Radiation Oncology, University Hospitals of Cleveland and Case Western Reserve University, Cleveland, Ohio. Electronic address: · Pubmed 25832684
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton (Surrey), UK. · Department of Medical Oncology, Kantonsspital St Gallen, St Gallen, Switzerland. · Department of Clinical Oncology, Bristol Haematology and Oncology Centre, Bristol, UK. · Oncology, Sanofi Oncology, Cambridge. · Department of Medicine: Section of Hematology & Medical Oncology and Department of Urology, Tulane University, New Orleans, USA. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton (Surrey), UK · Pubmed 25538172
  • College of Life Sciences, Jilin University, Changchun, P.R. China. · Department of Pathology, Tulane University School of Medicine, New Orleans, Louisiana, USA. · Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana, USA. · Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA. · Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana, USA. · Division of Comparative Pathology, Tulane National Primate Research Center, Covington, Louisiana, USA. · Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, Louisiana, USA. · Pubmed 26160840
  • College of Life Sciences, Jilin University, Changchun, China. Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. School of Nursing, Jilin University, Changchun, China. · Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · College of Life Sciences, Jilin University, Changchun, China. Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin. · Bio-X Program and Department of Radiology, Stanford University School of Medicine, Stanford, California. · Department of Pathology, New York University School of Medicine, New York, New York. · Department of Urology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. Department of Medicine, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana. · College of Life Sciences, Jilin University, Changchun, China. Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. National Engineering Laboratory for AIDS Vaccine, Jilin University, Changchun, China. · Pubmed 26060018
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • Harvard Medical School, Boston. · Department of Statistics, University of Connecticut, Storrs. · South Carolina College of Pharmacy and the Hollings Cancer Center, Charleston. · Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland. · Departments of Medicine and Urology, Tulane University, New Orleans. · Novartis, East Hanover. · Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA · Pubmed 25926039
  • Kantonsspital St Gallen, Department of Oncology and Hematology, St Gallen, Switzerland. Electronic address: · Tulane University, Department of Medicine and Urology, New Orleans, LA. · Kantonsspital St Gallen, Department of Oncology and Hematology, St Gallen, Switzerland. · Division of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland. · Prostate Cancer Targeted Therapies Group, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, ICR, Sutton, UK. · Sanofi-Aventis, Bridgewater, NJ. · Pubmed 25733056
  • Department of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA, USA, . · Department of Structural and Cellular Biology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA, USA; National Engineering Laboratory for AIDS Vaccine, College of Life Sciences, Jilin University, Changchun, Jilin, China, . · Pubmed 25532583
  • Harvard Medical School, Boston, MA, USA. · Department of Statistics, University of Connecticut, Storrs, CT, USA. · South Carolina College of Pharmacy, Hollings Cancer Center, Charleston, SC, USA. · Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA. · Department of Medicine and Urology, Tulane University, New Orleans, LA, USA. · Novartis, East Hanover, NJ, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 25348256
2014
  • Department of Urology, Tulane University School of Medicine, New Orleans, LA. Electronic address: · Department of Urology, Tulane University School of Medicine, New Orleans, LA. · Department of Medical Oncology, Tulane University School of Medicine, New Orleans, LA. · Pubmed 25283702
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA · Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA. · Pubmed 25232039
  • Department of Medicine and Urology, Tulane University School of Medicine, New Orleans, Louisiana, USA. · Pubmed 24675654
  • Hospital Sao Jose - Beneficencia Portuguesa de Sao Paulo, Sao Paulo, Brazil. Electronic address: · Hospital Sao Jose - Beneficencia Portuguesa de Sao Paulo, Sao Paulo, Brazil. · Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA, United States. · Pubmed 24613528
  • Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA. · Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA; Department of Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA 70112, USA; National Engineering Laboratory for AIDS Vaccine, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. · Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA; Department of Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA 70112, USA. · Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA; Department of Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA 70112, USA. · College of Life Sciences, Jilin University, China and Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. · Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA; Department of Urology, Tulane University School of Medicine, New Orleans, LA 70112, USA; Department of Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA 70112, USA. Electronic address: · Pubmed 24139549
  • Department of Urology, Tulane University School of Medicine, New Orleans, LA; Department of Hematology and Medical Oncology, Tulane University School of Medicine, New Orleans, LA. · Pubmed 25283704
  • Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA. · Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112, USA. · Pubmed 25073005
  • Department of Urology, Tulane University, 1430 Tulane Avenue, New Orleans, LA 70112, USA. · Pubmed 24861329
  • Department of Urology and Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA. · Pubmed 24625877
  • Office of Hematology and Oncology Products, U.S. Food and Drug Administration, Silver Spring, MD. Electronic address: · Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Office of Hematology and Oncology Products, U.S. Food and Drug Administration, Silver Spring, MD. · Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD. · Division of Biometrics V, Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD. · Department of Surgery, David H. Koch Chair, Memorial Sloan-Kettering Cancer Center, New York, NY. · Department of Urology, Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA. · University of Connecticut Health Center, Farmington, CT. · Johns Hopkins School of Medicine, Baltimore, MD. · American Cancer Society, Emory University, Atlanta, GA. · Laborde Professor for Cancer Research, Departments of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA. · Ronald H. Bloom Chair in Cancer Therapeutics, Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA. · Board Chairman Emeritus, Us TOO, International, Des Plaines, IL. · American Medical Systems, Minnetonka, MN. · Pubmed 24661332
2013
  • Tulane Cancer Center, New Orleans, Louisiana 70112, USA. · Pubmed 23650019
  • Department of Medicine, Tulane Medical School, Box SL-42, 1430 Tulane Avenue, New Orleans, LA 70112, USA. · Pubmed 23149889
2012
  • Laborde Professor for Cancer Research, Departments ofMedicine and Urology, Tulane Medical School, New Orleans, LA 70112, USA. · Pubmed 22522500
2011
  • Tulane Cancer Center, Tulane University, New Orleans, LA, USA. · Pubmed 22048000
  • Department of Medicine, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA 70112, USA. · Pubmed 21857688
  • Department of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112, USA. · Pubmed 21808270
  • Department of Medicine, Tulane Medical School, New Orleans, LA 70115, USA. · Pubmed 21499278
  • Department of Medicine, Tulane Medical School, New Orleans, LA, USA. · Pubmed 21358665
2010
  • Tulane Medical School New Orleans, LA, USA. · Pubmed 21208852
  • Department of Medicine and Urology, Tulane University, New Orleans, Louisiana 70115, USA. · Pubmed 20852653
  • Department of Medicine, Tulane University, New Orleans, Louisiana 70115, USA. · Pubmed 19589569
  • Departments of Urology and Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, SL-42 New Orleans, LA 70112, USA. · Pubmed 20818322
2009
2017
  • Stéphane Oudard, Georges Pompidou European Hospital, Rene Descartes University; Mustapha Chadjaa; Sanofi, Paris; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Antoine Thiery-Vuillemin, Centre Hospitalier Universitaire Minjoz Besançon, Besançon, France; Lisa Sengeløv, Herlev Hospital, Herlev; Gedske Daugaard, Copenhagen University Hospital, Rigshospitalet, Copenhagen; Steinbjørn Hansen, Odense University Hospital, Odense, Denmark; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Marie Hjälm-Eriksson, Karolinska University Hospital, Stockholm, Sweden; Jacek Jassem, Medical University of Gdansk, Gdansk, Poland; Orazio Caffo, Santa Chiara Hospital, Trento, Italy; Daniel Castellano, University Hospital 12 de Octubre, Madrid, Spain; Paul N. Mainwaring, Icon Cancer Care, Brisbane, Queensland, Australia; John Bernard, Sanofi, Cambridge, MA; Liji Shen, Sanofi, Bridgewater, NJ; and Oliver Sartor, Tulane Cancer Center, New Orleans, LA. · Pubmed 28753384
  • Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana-Farber Cancer Institute, Boston, MA; Marc Buyse, International Drug Development Institute; Bertrand Tombal, Université Catholique de Louvain, Louvain-la-Neuve; Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Susan Halabi, Duke University Medical Center, Durham, NC; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; Oliver Sartor, Tulane Medical School, New Orleans, LA; Howard Soule, Prostate Cancer Foundation, Santa Monica; Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles, CA; Noel W. Clarke, The Christie NHS Foundation Trust, Manchester; Matthew R. Sydes, University College London, London, United Kingdom; James J. Dignam, University of Chicago, Chicago, IL; Karim Fizazi, Institut Gustave-Roussy, Villejuif, France; Wendy R. Paruleker, Canadian Cancer Trials Group, Kingston, Ontario, Canada; and Scott G. Williams, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28796587
  • From Massachusetts General Hospital and Harvard Medical School, Boston (W.U.S., N.M.H., A.L.Z.); NRG Oncology Statistics and Data Management Center (W.S., J.J.D., S.L.P.) and Einstein Medical Center (K.L.Z.), Philadelphia; Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON (H.R.L., P.P.M., M.P.P.), Hospital Notre-Dame du Centre Hospitalier de l'Université de Montréal (J.-P.B.) and McGill University Health Centre (L.S.), Montreal, and Tom Baker Cancer Centre, Calgary, AB (A.G.B.) - all in Canada; Indiana University, Indianapolis (D.J.G.); Tulane University, New Orleans (O.S.); Mayo Clinic, Rochester, MN (T.M.P.); Medical College of Wisconsin, Milwaukee (C.A.F.L.); University of Michigan, Ann Arbor (F.Y.F.); University of Vermont Medical Center, Burlington (R.D.L.); Radiation Oncology Center, Sacramento (S.A.R.), and Cedars-Sinai Medical Center, Los Angeles (H.M.S.) - both in California; Wayne Radiation Oncology, Goldsboro, NC (K.J.K.); and the University of Chicago, Chicago (J.J.D.). · Pubmed 28146658
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
2014
  • Department of Urology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA. · Pubmed 24715691
  • Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA. · Pubmed 24722067
2013
  • Affiliations of authors: Department of Biostatistics and Bioinformatics, (SH, C-YL, EK), and Alliance Statistics and Data Center (SH), Duke University, Durham, NC; Departments of Medicine and Urology, University of California-San Francisco, San Francisco, CA (EJS); Division of Medical Oncology, Duke Prostate Center and the Duke Cancer Institute, Durham, NC (AJA); Departments of Medical Oncology and Urology, Yale University Cancer Center, New Haven, CT (DP); Department of Medical Oncology, San Camillo and Forlanini Hospital, Rome, Italy (CNS); Sanofi, Malvern, PA (LS); Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France (SO); Department of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, Surrey, United Kingdom (JdB); Urology Department, Tulane Cancer Center, New Orleans, LA (OS). · Pubmed 24136890
  • Susan Halabi, Andrew J. Armstrong, Ellen Kaplan, Chen-Yen Lin, and Nicole C. Solomon, Duke University, Durham, NC; Oliver Sartor, Tulane University, New Orleans, LA; Johann de Bono, Royal Marsden Hospital, Sutton, United Kingdom; and Eric J. Small, University of California at San Francisco, San Francisco, CA. · Pubmed 24101043
  • Tulane University School of Medicine, New Orleans, LA 70112, USA. · Pubmed 23146972
  • Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA 70112, USA. · Pubmed 22907191
2011
  • Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA. · Pubmed 21613449
Probable:    Harvard University   Contact    
2014
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA · Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA. · Pubmed 25232039
2009
2017
  • Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana-Farber Cancer Institute, Boston, MA; Marc Buyse, International Drug Development Institute; Bertrand Tombal, Université Catholique de Louvain, Louvain-la-Neuve; Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Susan Halabi, Duke University Medical Center, Durham, NC; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; Oliver Sartor, Tulane Medical School, New Orleans, LA; Howard Soule, Prostate Cancer Foundation, Santa Monica; Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles, CA; Noel W. Clarke, The Christie NHS Foundation Trust, Manchester; Matthew R. Sydes, University College London, London, United Kingdom; James J. Dignam, University of Chicago, Chicago, IL; Karim Fizazi, Institut Gustave-Roussy, Villejuif, France; Wendy R. Paruleker, Canadian Cancer Trials Group, Kingston, Ontario, Canada; and Scott G. Williams, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28796587
  • From Massachusetts General Hospital and Harvard Medical School, Boston (W.U.S., N.M.H., A.L.Z.); NRG Oncology Statistics and Data Management Center (W.S., J.J.D., S.L.P.) and Einstein Medical Center (K.L.Z.), Philadelphia; Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON (H.R.L., P.P.M., M.P.P.), Hospital Notre-Dame du Centre Hospitalier de l'Université de Montréal (J.-P.B.) and McGill University Health Centre (L.S.), Montreal, and Tom Baker Cancer Centre, Calgary, AB (A.G.B.) - all in Canada; Indiana University, Indianapolis (D.J.G.); Tulane University, New Orleans (O.S.); Mayo Clinic, Rochester, MN (T.M.P.); Medical College of Wisconsin, Milwaukee (C.A.F.L.); University of Michigan, Ann Arbor (F.Y.F.); University of Vermont Medical Center, Burlington (R.D.L.); Radiation Oncology Center, Sacramento (S.A.R.), and Cedars-Sinai Medical Center, Los Angeles (H.M.S.) - both in California; Wayne Radiation Oncology, Goldsboro, NC (K.J.K.); and the University of Chicago, Chicago (J.J.D.). · Pubmed 28146658
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
2013
  • Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 23273077
2012
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 22730461
  • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 22085233
2009
  • Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02115, USA. · Pubmed 19887483
  • Department of Epidemiology, Harvard School of Public Health, Harvard University, Cambridge, Massachusetts, USA. · Pubmed 19366828
  • Dana-Farber Cancer Institute/Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 19152438
2008
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 18302198
  • Harvard Medical School, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 18293426
  • Dana-Farber Cancer Institute, Dana 710-C, 44 Binney St, Boston, MA 02115, USA. · Pubmed 18281655
  • Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA. · Pubmed 18184327
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 148 total) written by Oliver A. Sartor about Prostatic Neoplasms:

  • Metastatic Prostate Cancer. 2018
  • Navigating the evolving therapeutic landscape in advanced prostate cancer. 2017
  • Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA. 2017
  • An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223. 2017
  • Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial. 2017
  • Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data. 2017
  • Hematologic Safety of Radium-223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA Trial. 2017
  • Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer. 2017
  • Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621. 2017
  • Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. 2017
Show List of Full Article Records
Google Searches

Learn more about Oliver A. Sartor using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in New Orleans
Tulane University
Harvard University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in New Orleans
2018
  • From Tulane Medical School, New Orleans (O.S.); and the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London (J.S.B.). · Pubmed 29412780
2017
  • Department of Surgery, Section of Urologic Oncology, School of Medicine, University of Colorado Denver, Aurora, CO. · Department of Medicine (Medical Oncology), Yale (Smilow) Cancer Center, New Haven, CT; Department of Urology, Yale (Smilow) Cancer Center, New Haven, CT. · Department of Medicine, Tulane Cancer Center, New Orleans, LA; Department of Urology, Tulane Cancer Center, New Orleans, LA. Electronic address: · Pubmed 28283376
  • Departments of Medicine and Urology, Tulane Cancer Center, New Orleans, USA. · Academic Unit of Clinical Oncology, University of Sheffield, Weston Park Hospital, Sheffield, UK. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway. · Department of Clinical Oncology, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland. · Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, USA. · Department of Medical Oncology and Radiotherapy, University of Oslo, Norwegian Radium Hospital, Oslo, Norway. · Oncology Global Medical Affairs, Bayer HealthCare Pharmaceuticals, Whippany, USA. · Infinity Analytics Group Inc, Madison. · Department of Statistics, Oncology, Bayer HealthCare Pharmaceuticals, Whippany, USA. · Quantitative Health Sciences, Cleveland Clinic, Cleveland, USA. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK. · Pubmed 28453701
  • The Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, UK. Electronic address: · Bayer HealthCare Pharmaceuticals, 100 Bayer Boulevard, Whippany, NJ 07981, USA. · Yale University, New Haven, CT 06520, USA. · Comprehensive Cancer Center of Nevada, 3730 South Eastern Avenue, Las Vegas, NV 89169, USA. · Karolinska University Hospital, SE-171 76, Stockholm, Sweden. · Tulane Cancer Center, 150 South Liberty Street, New Orleans, LA 70112, USA. · Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Weston Park Hospital, Sheffield, UK. · Pubmed 27930924
  • Comprehensive Cancer Centers of Nevada, Department of Medical Oncology, Las Vegas, NV. Electronic address: · Weston Park Hospital, Department of Oncology, Sheffield, UK. · Washington University School of Medicine, Radiation Oncology, St Louis, MO. · Karolinska University Hospital, Department of Oncology, Stockholm, Sweden. · Queen's University, Centre for Cancer Research and Cell Biology, Belfast, UK. · Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Academic Urology Unit, Sutton, UK. · Umeå University, Department of Radiation Sciences, Umeå, Sweden. · Statisticon AB, Biostatistics Department, Uppsala, Sweden. · Bayer HealthCare Pharmaceuticals, Global Medical Affairs Oncology, Whippany, NJ. · Bayer HealthCare Pharmaceuticals, US Medical Affairs Oncology, Whippany, NJ. · Tulane Cancer Center, Departments of Medicine and Urology, New Orleans, LA. · Pubmed 27613490
  • Associate Professor of Radiation Oncology, Department of Radiation Oncology, Stanford University, Stanford, CA. · Director, Molecular Imaging Program, National Cancer Institute, Rockville, MD. · Section Head, Surgical Pathology, Robert J. Tomisch Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH. · Hematology/Oncology Section Chief and Professor of Radiation Oncology, Departments of Medicine and Urology, Tulane Medical School, New Orleans, LA. · Chair, Department of Radiation Oncology, and Professor of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA. · Chair, Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN. · Chair, Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH. · Chief of Urologic Oncology, Department of Urology, University of Washington, and Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 28222223
  • College of Life Sciences, National Engineering Laboratory for AIDS Vaccine, Jilin University, Changchun, China. · Department of Structural and Cellular Biology, Tulane Cancer Center, New Orleans, Louisiana. · Department of Pathology and Laboratory Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Urology, Tulane Cancer Center, New Orleans, Louisiana. · Department of Medicine, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Pathology, New York University School of Medicine, New York, New York. · College of Life Sciences, National Engineering Laboratory for AIDS Vaccine, Jilin University, Changchun, China. · Pubmed 27671337
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address: · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. · Department of Medicine, Tulane Cancer Center, New Orleans, LA. · Pubmed 27651103
2016
  • From the Departments of Medicine & Urology, Tulane Medical School, New Orleans, LA. · Pubmed 27749328
  • Department of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Urology, Tulane Cancer Center, New Orleans, Louisiana. · Marie Curie Research Wing for Oncology, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom. · Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, United Kingdom. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, University of Nevada School of Medicine and Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. · Department of Global Clinical Development, Bayer HealthCare Pharmaceuticals, Whippany, New Jersey. · Department of Study Management Europe, Bayer AS (formerly Algeta ASA), Oslo, Norway. · Department of Biostatistics, Statisticon AB, Uppsala, Sweden. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 27004570
  • Department of Oncology, Karolinska University Hospital, Stockholm, Sweden · Bayer HealthCare, Whippany. · Departments of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, USA. · Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield. · Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK. · Department of Statistics, Yale University, New Haven, USA. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK. · Pubmed 26912557
  • Department of Oncology, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland; Department of Internal Medicine, Stadtspital Waid, Tièchestrasse 99, 8037 Zurich, Switzerland. · Clinical Trial Unit, CTU, University Hospital of Basel, Schanzenstrasse 55, 4031 Basel, Switzerland. · Department of Oncology, University Hospital of Basel, Petersgraben 4, 4031 Basel, Switzerland. · Erasmus MC, and ErasmusMC Cancer Institute, PO Box 5201, 3008 AE Rotterdam, The Netherlands. · Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5, UK. · Department of Medicine & Urology, Tulane Cancer Center, 1430 Tulane Avenue, SL-42, New Orleans, 70112 LA, USA. · Pubmed 26829012
  • Royal Marsden Hospital, Sutton, London, UK. Electronic address: · Cancer Treatment Centers of America, Tulsa, OK, USA. · Washington University School of Medicine, St Louis, MO, USA. · Center for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Norwegian Radium Hospital, Oslo, Norway. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · University of Sheffield, Sheffield, South Yorkshire, UK. · Karolinska University Hospital, Stockholm, Sweden. · Tulane Cancer Center, New Orleans, LA, USA. · Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA. · St. James University Hospital, Leeds, Yorkshire, UK. · Pubmed 27344296
2015
  • Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Department of Medicine: Section of Hematology & Medical Oncology and Department of Urology, Tulane Medical School, New Orleans, LA. · Department of Pathology, University of Arizona College of Medicine, Tucson, AZ. · College of Pharmacy, Medical University of South Carolina Cancer Center, Charleston, SC. · Pubmed 25623704
  • Tulane Medical School, New Orleans, LA, USA. · Pubmed 25510569
  • San Bernardino Urological Associates, 489 E. 21 Street, San Bernardino, CA 92404, USA. Electronic address: · Medicine and Urology Departments, Tulane School of Medicine, Box SL-42 1430 Tulane Ave, New Orleans, USA. · Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, 111 South 11th Street, Philadelphia, PA 19107, USA. · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, USA. · GlaxoSmithKline, 5 Moore Drive, PO Box 13398, Research Triangle Park, North Carolina, NC 27709, USA. · Pubmed 26048455
  • Departments of Medicine and Urology, Tulane Medical School, New Orleans, LA. · Oxford Outcomes Inc, an ICON plc company, Bethesda, MD. Electronic address: · Oxford Outcomes Inc, an ICON plc company, Bethesda, MD. · Millennium Pharmaceuticals Inc, The Takeda Oncology Company, Cambridge, MA. · Bruce Wong & Associates Inc. · Pubmed 25262852
  • Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana. · Pubmed 26452186
2014
  • Princess Margaret Hospital, Toronto, ON, Canada. Electronic address: · Durham VA Medical Center and Duke University Medical Center, Durham, NC, USA. · BC Cancer Agency, Vancouver, BC, Canada. · Seattle Cancer Centre Alliance, Seattle, WA, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Royal Marsden NHS Foundation Trust, Sutton, UK. · Tulane Cancer Center, New Orleans, LA, USA. · University of Montreal Hospital Center, Montreal, PQ, Canada. · Pubmed 23957948
  • Mount Vernon Cancer Centre, Northwood, Middlesex, UK. Electronic address: · Tulane Cancer Center, New Orleans, LA, USA. · Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Ullevål University Hospital, Oslo, Norway. · Haukeland University Hospital, Bergen, Norway. · Christie Hospital, Manchester, UK. · St James's University Hospital, Leeds, UK. · Karolinska University Hospital, Stockholm, Sweden. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA. · Algeta ASA (Bayer), Oslo, Norway. · The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 25439694
  • Tulane Cancer Center, New Orleans, LA, USA. Electronic address: · Weston Park Hospital, Sheffield Cancer Research Centre, Sheffield, UK. · Karolinska University Hospital, Radiumhemmet, Stockholm, Sweden. · Akershus University Hospital, Department of Oncology, Lørenskog, Norway. · Haukeland University Hospital, Bergen, Norway. · Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. · Oslo University Hospital, Radiumhospital, Oslo, Norway. · Hospital Chomutov, Nuclear Medicine Department, Chomutov, Czech Republic. · Centrum Onkologii-Instytut im Marii Skodowskiej-Curie, Warsaw, Poland. · Christie Hospital, Manchester, UK. · Umeå University, Department of Radiation Sciences, Oncology, Sweden. · Ullevål University Hospital, Oslo, Norway. · Mount Vernon Hospital Cancer Centre, Northwood, Middlesex, UK. · Cancer Research Unit, University of Warwick, Coventry, UK; University Hospital, Birmingham NHS Trust, Birmingham, UK. · St Olavs Hospital, Trondheim, Norway. · Clatterbridge Cancer Centre, Clatterbridge Health Park, Bebington, Wirral, UK. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Algeta ASA, Kjelsaas, Oslo, Norway. · Bayer Healthcare, Whippany, NJ, USA. · Norwegian Radium Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway. · The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 24836273
  • Department of Urology and Medicine, Tulane Medical School, Tulane, New Orleans, Louisiana, USA. · Pubmed 24994787
  • Department of Urology, Medical University of South Carolina, Charleston, SC. · Tulane Cancer Center, New Orleans, LA. · Hollings National Cancer Institute Comprehensive Cancer Center, Charleston, SC; Center for Medication Safety and Efficacy, the Medical University of South Carolina, Charleston, SC; University of South Carolina, Columbia, SC. · Pubmed 24680449
2013
2009
2008
  • Stanley Scott Cancer Center, New Orleans, Louisiana, USA. · Pubmed 18681353
2012
  • Department of Structural & Cellular Biology, School of Medicine, New Orleans, LA, USA. · Pubmed 22461511
  • Division of Hematology/Oncology, Department of Medicine, Tulane Cancer Center, New Orleans, Louisiana, USA. · Pubmed 22453334
2011
  • Tulane Medical School, New Orleans, Los Angeles and USA. · Pubmed 21734581
Tulane University
2017
  • Sage Bionetworks, Seattle, WA, USA. · Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Department of Mathematics and Statistics, University of Turku, Turku, Finland; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. · Department of Pharmacology and Computational Biosciences Program, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. · Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. · Department of Information Technology, University of Turku, Turku, Finland. · Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland; Department of Pathology (HUSLAB), Helsinki University Hospital, Helsinki, Finland. · Sanofi, Bridgewater, NJ, USA. · AstraZeneca, Gaithersburg, MD, USA. · IBM T J Watson Research Center, IBM, Yorktown Heights, NY, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Genitourinary Medical Oncology Program, Division of Hematology and Oncology, University of California, San Francisco, CA, USA. · Genitourinary Oncology Services, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Tulane Cancer Center, Tulane University, New Orleans, LA, USA. · Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA; The Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Lyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Department of Pharmacology and Computational Biosciences Program, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA; University of Colorado Comprehensive Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. Electronic address: · Pubmed 27864015
  • Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania. · NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania. · Tulane University Cancer Center, New Orleans, Louisiana. · Department of Urology, McMaster University, Hamilton, Ontario, Canada. · Gamma Knife Center, University of Minnesota Medical Center, Minneapolis, Minnesota. · Minneapolis Radiation Oncology, Minneapolis, Minnesota. · Department of Radiation Oncology, Virginia Mason Medical Center, Seattle, Washington. · Department of Radiation Oncology, Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin. · Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri. · Southeast Radiation Oncology, Charlotte, North Carolina. · Arizona Oncology Services, Phoenix, Arizona. · Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California. · Pubmed 28323339
  • College of Life Sciences, National Engineering Laboratory for AIDS Vaccine, Jilin University, Changchun, China. · Department of Structural and Cellular Biology, Tulane Cancer Center, New Orleans, Louisiana. · Department of Pathology and Laboratory Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Urology, Tulane Cancer Center, New Orleans, Louisiana. · Department of Medicine, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Pathology, New York University School of Medicine, New York, New York. · College of Life Sciences, National Engineering Laboratory for AIDS Vaccine, Jilin University, Changchun, China. · Pubmed 27671337
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Urology and Medicine, Tulane University School of Medicine, New Orleans, Los Angeles. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27489290
  • Institute of Cancer Research, London, United Kingdom · Johns Hopkins University, Baltimore, MD · Tulane University School of Medicine, New Orleans, LA · Pubmed 29083122
2016
  • Department of Urology, College of Medicine, Howard University, Washington, DC. Electronic address: · Dendreon Pharmaceuticals Inc, Seattle, WA. · Departments of Urology and Medicine, Tulane University School of Medicine, New Orleans, LA. · Pubmed 26786562
  • Department of Urology, Tulane University School of Medicine, New Orleans, LA; Southeast Louisiana Veterans Health Care Services, New Orleans, LA. · Department of Urology, Tulane University School of Medicine, New Orleans, LA. · Department of Pathology, Tulane University School of Medicine, New Orleans, LA. · Department of Urology, Tulane University School of Medicine, New Orleans, LA; Southeast Louisiana Veterans Health Care Services, New Orleans, LA. Electronic address: · Pubmed 27155916
  • Department of Structural and Cellular Biology, Tulane University, New Orleans, LA 70112, USA. · Department of Dermatology, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524001, China. · Department of Pathology, Ochsner Clinic Foundation, New Orleans, LA 70130, USA. · Department of Computer Science and Biostatistics Facility of RCMI Cancer Research Center, Xavier University of Louisiana, New Orleans, LA 70125, USA. · Department of Pathology and Laboratory Medicine, Tulane University, New Orleans, LA 70112, USA. · Tulane Cancer Center, Louisiana Cancer Research Consortium, Tulane University, New Orleans, LA 70112, USA. · Tulane Center for Stem Cell Research and Regenerative Medicine, Tulane University, New Orleans, LA 70112, USA. · Department of Urology, Tulane University, New Orleans, LA 70112, USA. · Department of Medicine, Tulane University, New Orleans, LA 70112, USA. · Department of Biostatistics and Bioinformatics, Tulane University, New Orleans, LA 70112, USA. · Proteomics/Mass Spectrometry Facility, University at Albany, Rensselaer, NY 12144, USA. · Department of Orthopaedic Surgery and Tulane Center for Aging, Tulane University, New Orleans, LA 70112, USA. · Pubmed 26871944
  • Tulane University School of Medicine, New Orleans, LA. · Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA. · Department of Internal Medicine, University of Massachusetts Medical School, Worcester, MA. · Department of Urology, Tulane University School of Medicine, New Orleans, LA. · Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA; Departments of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA. Electronic address: · Pubmed 26703881
  • Tulane University School of Medicine, New Orleans, LA. · Tulane Cancer Center, New Orleans, LA. · Tulane University School of Medicine, New Orleans, LA; Tulane Cancer Center, New Orleans, LA. Electronic address: · Pubmed 26684813
2015
  • Tulane University School of Medicine, New Orleans, LA. · The Southern Network on Adverse Reaction (SONAR) project, the South Carolina Center of Economic Excellence for Medication Safety, the South Carolina College of Pharmacy, University of South Carolina, Columbia, SC; The Hollings Cancer Center, Medical University of South Carolina, Charleston, SC. · Pubmed 25530377
  • Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Department of Internal Medicine, Section of Medical Oncology, UAB Medical Center, Birmingham, AL, USA. · Department of Medicine and Urology, Tulane University, New Orleans, LA, USA. · Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 26153564
  • Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York. · Departments of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana. · Department of Clinical Oncology, Institute of Cancer Research, Sutton, United Kingdom. · Department of Oncology, Norwegian Radium Hospital and Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Radiation Oncology, University Hospitals of Cleveland and Case Western Reserve University, Cleveland, Ohio. Electronic address: · Pubmed 25832684
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton (Surrey), UK. · Department of Medical Oncology, Kantonsspital St Gallen, St Gallen, Switzerland. · Department of Clinical Oncology, Bristol Haematology and Oncology Centre, Bristol, UK. · Oncology, Sanofi Oncology, Cambridge. · Department of Medicine: Section of Hematology & Medical Oncology and Department of Urology, Tulane University, New Orleans, USA. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton (Surrey), UK · Pubmed 25538172
  • College of Life Sciences, Jilin University, Changchun, P.R. China. · Department of Pathology, Tulane University School of Medicine, New Orleans, Louisiana, USA. · Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana, USA. · Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA. · Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana, USA. · Division of Comparative Pathology, Tulane National Primate Research Center, Covington, Louisiana, USA. · Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, Louisiana, USA. · Pubmed 26160840
  • College of Life Sciences, Jilin University, Changchun, China. Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. School of Nursing, Jilin University, Changchun, China. · Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · College of Life Sciences, Jilin University, Changchun, China. Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin. · Bio-X Program and Department of Radiology, Stanford University School of Medicine, Stanford, California. · Department of Pathology, New York University School of Medicine, New York, New York. · Department of Urology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. Department of Medicine, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana. · College of Life Sciences, Jilin University, Changchun, China. Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana. National Engineering Laboratory for AIDS Vaccine, Jilin University, Changchun, China. · Pubmed 26060018
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • Harvard Medical School, Boston. · Department of Statistics, University of Connecticut, Storrs. · South Carolina College of Pharmacy and the Hollings Cancer Center, Charleston. · Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland. · Departments of Medicine and Urology, Tulane University, New Orleans. · Novartis, East Hanover. · Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA · Pubmed 25926039
  • Kantonsspital St Gallen, Department of Oncology and Hematology, St Gallen, Switzerland. Electronic address: · Tulane University, Department of Medicine and Urology, New Orleans, LA. · Kantonsspital St Gallen, Department of Oncology and Hematology, St Gallen, Switzerland. · Division of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland. · Prostate Cancer Targeted Therapies Group, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, ICR, Sutton, UK. · Sanofi-Aventis, Bridgewater, NJ. · Pubmed 25733056
  • Department of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA, USA, . · Department of Structural and Cellular Biology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA, USA; National Engineering Laboratory for AIDS Vaccine, College of Life Sciences, Jilin University, Changchun, Jilin, China, . · Pubmed 25532583
  • Harvard Medical School, Boston, MA, USA. · Department of Statistics, University of Connecticut, Storrs, CT, USA. · South Carolina College of Pharmacy, Hollings Cancer Center, Charleston, SC, USA. · Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA. · Department of Medicine and Urology, Tulane University, New Orleans, LA, USA. · Novartis, East Hanover, NJ, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 25348256
2014
  • Department of Urology, Tulane University School of Medicine, New Orleans, LA. Electronic address: · Department of Urology, Tulane University School of Medicine, New Orleans, LA. · Department of Medical Oncology, Tulane University School of Medicine, New Orleans, LA. · Pubmed 25283702
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA · Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA. · Pubmed 25232039
  • Department of Medicine and Urology, Tulane University School of Medicine, New Orleans, Louisiana, USA. · Pubmed 24675654
  • Hospital Sao Jose - Beneficencia Portuguesa de Sao Paulo, Sao Paulo, Brazil. Electronic address: · Hospital Sao Jose - Beneficencia Portuguesa de Sao Paulo, Sao Paulo, Brazil. · Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA, United States. · Pubmed 24613528
  • Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA. · Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA; Department of Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA 70112, USA; National Engineering Laboratory for AIDS Vaccine, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. · Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA; Department of Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA 70112, USA. · Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA; Department of Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA 70112, USA. · College of Life Sciences, Jilin University, China and Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. · Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA; Department of Urology, Tulane University School of Medicine, New Orleans, LA 70112, USA; Department of Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA 70112, USA. Electronic address: · Pubmed 24139549
  • Department of Urology, Tulane University School of Medicine, New Orleans, LA; Department of Hematology and Medical Oncology, Tulane University School of Medicine, New Orleans, LA. · Pubmed 25283704
  • Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA. · Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112, USA. · Pubmed 25073005
  • Department of Urology, Tulane University, 1430 Tulane Avenue, New Orleans, LA 70112, USA. · Pubmed 24861329
  • Department of Urology and Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA. · Pubmed 24625877
  • Office of Hematology and Oncology Products, U.S. Food and Drug Administration, Silver Spring, MD. Electronic address: · Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Office of Hematology and Oncology Products, U.S. Food and Drug Administration, Silver Spring, MD. · Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD. · Division of Biometrics V, Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD. · Department of Surgery, David H. Koch Chair, Memorial Sloan-Kettering Cancer Center, New York, NY. · Department of Urology, Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA. · University of Connecticut Health Center, Farmington, CT. · Johns Hopkins School of Medicine, Baltimore, MD. · American Cancer Society, Emory University, Atlanta, GA. · Laborde Professor for Cancer Research, Departments of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA. · Ronald H. Bloom Chair in Cancer Therapeutics, Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA. · Board Chairman Emeritus, Us TOO, International, Des Plaines, IL. · American Medical Systems, Minnetonka, MN. · Pubmed 24661332
2013
  • Tulane Cancer Center, New Orleans, Louisiana 70112, USA. · Pubmed 23650019
  • Department of Medicine, Tulane Medical School, Box SL-42, 1430 Tulane Avenue, New Orleans, LA 70112, USA. · Pubmed 23149889
2012
  • Laborde Professor for Cancer Research, Departments ofMedicine and Urology, Tulane Medical School, New Orleans, LA 70112, USA. · Pubmed 22522500
2011
  • Tulane Cancer Center, Tulane University, New Orleans, LA, USA. · Pubmed 22048000
  • Department of Medicine, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA 70112, USA. · Pubmed 21857688
  • Department of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112, USA. · Pubmed 21808270
  • Department of Medicine, Tulane Medical School, New Orleans, LA 70115, USA. · Pubmed 21499278
  • Department of Medicine, Tulane Medical School, New Orleans, LA, USA. · Pubmed 21358665
2010
  • Tulane Medical School New Orleans, LA, USA. · Pubmed 21208852
  • Department of Medicine and Urology, Tulane University, New Orleans, Louisiana 70115, USA. · Pubmed 20852653
  • Department of Medicine, Tulane University, New Orleans, Louisiana 70115, USA. · Pubmed 19589569
  • Departments of Urology and Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, SL-42 New Orleans, LA 70112, USA. · Pubmed 20818322
2009
2017
  • Stéphane Oudard, Georges Pompidou European Hospital, Rene Descartes University; Mustapha Chadjaa; Sanofi, Paris; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Antoine Thiery-Vuillemin, Centre Hospitalier Universitaire Minjoz Besançon, Besançon, France; Lisa Sengeløv, Herlev Hospital, Herlev; Gedske Daugaard, Copenhagen University Hospital, Rigshospitalet, Copenhagen; Steinbjørn Hansen, Odense University Hospital, Odense, Denmark; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Marie Hjälm-Eriksson, Karolinska University Hospital, Stockholm, Sweden; Jacek Jassem, Medical University of Gdansk, Gdansk, Poland; Orazio Caffo, Santa Chiara Hospital, Trento, Italy; Daniel Castellano, University Hospital 12 de Octubre, Madrid, Spain; Paul N. Mainwaring, Icon Cancer Care, Brisbane, Queensland, Australia; John Bernard, Sanofi, Cambridge, MA; Liji Shen, Sanofi, Bridgewater, NJ; and Oliver Sartor, Tulane Cancer Center, New Orleans, LA. · Pubmed 28753384
  • Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana-Farber Cancer Institute, Boston, MA; Marc Buyse, International Drug Development Institute; Bertrand Tombal, Université Catholique de Louvain, Louvain-la-Neuve; Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Susan Halabi, Duke University Medical Center, Durham, NC; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; Oliver Sartor, Tulane Medical School, New Orleans, LA; Howard Soule, Prostate Cancer Foundation, Santa Monica; Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles, CA; Noel W. Clarke, The Christie NHS Foundation Trust, Manchester; Matthew R. Sydes, University College London, London, United Kingdom; James J. Dignam, University of Chicago, Chicago, IL; Karim Fizazi, Institut Gustave-Roussy, Villejuif, France; Wendy R. Paruleker, Canadian Cancer Trials Group, Kingston, Ontario, Canada; and Scott G. Williams, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28796587
  • From Massachusetts General Hospital and Harvard Medical School, Boston (W.U.S., N.M.H., A.L.Z.); NRG Oncology Statistics and Data Management Center (W.S., J.J.D., S.L.P.) and Einstein Medical Center (K.L.Z.), Philadelphia; Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON (H.R.L., P.P.M., M.P.P.), Hospital Notre-Dame du Centre Hospitalier de l'Université de Montréal (J.-P.B.) and McGill University Health Centre (L.S.), Montreal, and Tom Baker Cancer Centre, Calgary, AB (A.G.B.) - all in Canada; Indiana University, Indianapolis (D.J.G.); Tulane University, New Orleans (O.S.); Mayo Clinic, Rochester, MN (T.M.P.); Medical College of Wisconsin, Milwaukee (C.A.F.L.); University of Michigan, Ann Arbor (F.Y.F.); University of Vermont Medical Center, Burlington (R.D.L.); Radiation Oncology Center, Sacramento (S.A.R.), and Cedars-Sinai Medical Center, Los Angeles (H.M.S.) - both in California; Wayne Radiation Oncology, Goldsboro, NC (K.J.K.); and the University of Chicago, Chicago (J.J.D.). · Pubmed 28146658
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
2014
  • Department of Urology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA. · Pubmed 24715691
  • Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA. · Pubmed 24722067
2013
  • Affiliations of authors: Department of Biostatistics and Bioinformatics, (SH, C-YL, EK), and Alliance Statistics and Data Center (SH), Duke University, Durham, NC; Departments of Medicine and Urology, University of California-San Francisco, San Francisco, CA (EJS); Division of Medical Oncology, Duke Prostate Center and the Duke Cancer Institute, Durham, NC (AJA); Departments of Medical Oncology and Urology, Yale University Cancer Center, New Haven, CT (DP); Department of Medical Oncology, San Camillo and Forlanini Hospital, Rome, Italy (CNS); Sanofi, Malvern, PA (LS); Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France (SO); Department of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, Surrey, United Kingdom (JdB); Urology Department, Tulane Cancer Center, New Orleans, LA (OS). · Pubmed 24136890
  • Susan Halabi, Andrew J. Armstrong, Ellen Kaplan, Chen-Yen Lin, and Nicole C. Solomon, Duke University, Durham, NC; Oliver Sartor, Tulane University, New Orleans, LA; Johann de Bono, Royal Marsden Hospital, Sutton, United Kingdom; and Eric J. Small, University of California at San Francisco, San Francisco, CA. · Pubmed 24101043
  • Tulane University School of Medicine, New Orleans, LA 70112, USA. · Pubmed 23146972
  • Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA 70112, USA. · Pubmed 22907191
2011
  • Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA. · Pubmed 21613449
Harvard University
2014
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA · Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA. · Pubmed 25232039
2009
2017
  • Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana-Farber Cancer Institute, Boston, MA; Marc Buyse, International Drug Development Institute; Bertrand Tombal, Université Catholique de Louvain, Louvain-la-Neuve; Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Susan Halabi, Duke University Medical Center, Durham, NC; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; Oliver Sartor, Tulane Medical School, New Orleans, LA; Howard Soule, Prostate Cancer Foundation, Santa Monica; Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles, CA; Noel W. Clarke, The Christie NHS Foundation Trust, Manchester; Matthew R. Sydes, University College London, London, United Kingdom; James J. Dignam, University of Chicago, Chicago, IL; Karim Fizazi, Institut Gustave-Roussy, Villejuif, France; Wendy R. Paruleker, Canadian Cancer Trials Group, Kingston, Ontario, Canada; and Scott G. Williams, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28796587
  • From Massachusetts General Hospital and Harvard Medical School, Boston (W.U.S., N.M.H., A.L.Z.); NRG Oncology Statistics and Data Management Center (W.S., J.J.D., S.L.P.) and Einstein Medical Center (K.L.Z.), Philadelphia; Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON (H.R.L., P.P.M., M.P.P.), Hospital Notre-Dame du Centre Hospitalier de l'Université de Montréal (J.-P.B.) and McGill University Health Centre (L.S.), Montreal, and Tom Baker Cancer Centre, Calgary, AB (A.G.B.) - all in Canada; Indiana University, Indianapolis (D.J.G.); Tulane University, New Orleans (O.S.); Mayo Clinic, Rochester, MN (T.M.P.); Medical College of Wisconsin, Milwaukee (C.A.F.L.); University of Michigan, Ann Arbor (F.Y.F.); University of Vermont Medical Center, Burlington (R.D.L.); Radiation Oncology Center, Sacramento (S.A.R.), and Cedars-Sinai Medical Center, Los Angeles (H.M.S.) - both in California; Wayne Radiation Oncology, Goldsboro, NC (K.J.K.); and the University of Chicago, Chicago (J.J.D.). · Pubmed 28146658
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
2013
  • Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 23273077
2012
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 22730461
  • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 22085233
2009
  • Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02115, USA. · Pubmed 19887483
  • Department of Epidemiology, Harvard School of Public Health, Harvard University, Cambridge, Massachusetts, USA. · Pubmed 19366828
  • Dana-Farber Cancer Institute/Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 19152438
2008
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 18302198
  • Harvard Medical School, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 18293426
  • Dana-Farber Cancer Institute, Dana 710-C, 44 Binney St, Boston, MA 02115, USA. · Pubmed 18281655
  • Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA. · Pubmed 18184327
University of California San Francisco
2014
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA · Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA. · Pubmed 25232039
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
2013
  • Affiliations of authors: Department of Biostatistics and Bioinformatics, (SH, C-YL, EK), and Alliance Statistics and Data Center (SH), Duke University, Durham, NC; Departments of Medicine and Urology, University of California-San Francisco, San Francisco, CA (EJS); Division of Medical Oncology, Duke Prostate Center and the Duke Cancer Institute, Durham, NC (AJA); Departments of Medical Oncology and Urology, Yale University Cancer Center, New Haven, CT (DP); Department of Medical Oncology, San Camillo and Forlanini Hospital, Rome, Italy (CNS); Sanofi, Malvern, PA (LS); Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France (SO); Department of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, Surrey, United Kingdom (JdB); Urology Department, Tulane Cancer Center, New Orleans, LA (OS). · Pubmed 24136890
  • Susan Halabi, Andrew J. Armstrong, Ellen Kaplan, Chen-Yen Lin, and Nicole C. Solomon, Duke University, Durham, NC; Oliver Sartor, Tulane University, New Orleans, LA; Johann de Bono, Royal Marsden Hospital, Sutton, United Kingdom; and Eric J. Small, University of California at San Francisco, San Francisco, CA. · Pubmed 24101043
2011
  • Division of Hematology and Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA. · Pubmed 22361784
University of Arizona
2014
  • Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · University of Arizona College of Medicine, Tucson, AZ. · Tulane University School of Medicine, New Orleans, LA. · The Southern Network on Adverse Reaction (SONAR) project, the South Carolina Center of Economic Excellence for Medication Safety, the South Carolina College of Pharmacy, University of South Carolina, Columbia, SC; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC. · Pubmed 25443906
68 Other Locations Show
Yearly article counts 114121822181315811124
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.